• Info
  • Insider Ownership

Insider Trading & Ownership of Derek DiRocco

Location
San Francisco, CA
Summary
The estimated net worth of Derek DiRocco is at least $212,536 dollars as of 20 Feb 2026. Derek DiRocco is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $212.5K.
Signature
/s/ Adam Levy, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Derek DiRocco and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Derek DiRocco has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $212,536.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Mineralys Therapeutics, Inc. ($212,536).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Derek DiRocco

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MLYS Mineralys Therapeutics, Inc. Director $212,536 19 Feb 2026
ETNB 89bio, Inc. Director 30 Oct 2025
ACRV Acrivon Therapeutics, Inc. Director 13 Jun 2025
EVMN Evommune, Inc. Director 05 Nov 2025
ITOS iTeos Therapeutics, Inc. Director 13 Jun 2023
HOWL Werewolf Therapeutics, Inc. Director 24 May 2024

Insider Transactions Reported by Derek DiRocco:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored